Cargando…

2018–2019 Drug Updates in Solid Tumors

Sally Barbour, PharmD, BCOP, CPP, FHOPA, updated attendees on the FDA-approved therapies for initial or expanded indications for solid tumors across the past year, as well as their supporting clinical trial data and best practices for safe and effective dosing and administration, drug monitoring, an...

Descripción completa

Detalles Bibliográficos
Autor principal: Barbour, Sally
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Harborside Press LLC 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7857315/
https://www.ncbi.nlm.nih.gov/pubmed/33598321
http://dx.doi.org/10.6004/jadpro.2020.11.3.8
_version_ 1783646423593517056
author Barbour, Sally
author_facet Barbour, Sally
author_sort Barbour, Sally
collection PubMed
description Sally Barbour, PharmD, BCOP, CPP, FHOPA, updated attendees on the FDA-approved therapies for initial or expanded indications for solid tumors across the past year, as well as their supporting clinical trial data and best practices for safe and effective dosing and administration, drug monitoring, and adverse event management.
format Online
Article
Text
id pubmed-7857315
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Harborside Press LLC
record_format MEDLINE/PubMed
spelling pubmed-78573152021-02-16 2018–2019 Drug Updates in Solid Tumors Barbour, Sally J Adv Pract Oncol Meeting Reports Sally Barbour, PharmD, BCOP, CPP, FHOPA, updated attendees on the FDA-approved therapies for initial or expanded indications for solid tumors across the past year, as well as their supporting clinical trial data and best practices for safe and effective dosing and administration, drug monitoring, and adverse event management. Harborside Press LLC 2020-04 2020-04-01 /pmc/articles/PMC7857315/ /pubmed/33598321 http://dx.doi.org/10.6004/jadpro.2020.11.3.8 Text en © 2020 Harborside™ http://creativecommons.org/licenses/by-nc-nd/3.0/ This article is distributed under the terms of the Creative Commons Attribution Non-Commercial Non-Derivative License, which permits unrestricted non-commercial and non-derivative use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Meeting Reports
Barbour, Sally
2018–2019 Drug Updates in Solid Tumors
title 2018–2019 Drug Updates in Solid Tumors
title_full 2018–2019 Drug Updates in Solid Tumors
title_fullStr 2018–2019 Drug Updates in Solid Tumors
title_full_unstemmed 2018–2019 Drug Updates in Solid Tumors
title_short 2018–2019 Drug Updates in Solid Tumors
title_sort 2018–2019 drug updates in solid tumors
topic Meeting Reports
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7857315/
https://www.ncbi.nlm.nih.gov/pubmed/33598321
http://dx.doi.org/10.6004/jadpro.2020.11.3.8
work_keys_str_mv AT barboursally 20182019drugupdatesinsolidtumors